- Home
- REPL vs VLGEA Comparison
REPL vs VLGEA Comparison
Compare REPL & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- VLGEA
- Stock Information
- Founded
- REPL 2015
- VLGEA 1937
- Country
- REPL United States
- VLGEA United States
- Employees
- REPL N/A
- VLGEA N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- VLGEA Food Chains
- Sector
- REPL Health Care
- VLGEA Consumer Staples
- Exchange
- REPL Nasdaq
- VLGEA Nasdaq
- Market Cap
- REPL 578.4M
- VLGEA 532.5M
- IPO Year
- REPL 2018
- VLGEA N/A
- Fundamental
- Price
- REPL $7.71
- VLGEA $36.26
- Analyst Decision
- REPL Strong Buy
- VLGEA
- Analyst Count
- REPL 6
- VLGEA 0
- Target Price
- REPL $20.00
- VLGEA N/A
- AVG Volume (30 Days)
- REPL 1.1M
- VLGEA 42.8K
- Earning Date
- REPL 05-19-2025
- VLGEA 06-03-2025
- Dividend Yield
- REPL N/A
- VLGEA 2.76%
- EPS Growth
- REPL N/A
- VLGEA 3.71
- EPS
- REPL N/A
- VLGEA 3.65
- Revenue
- REPL N/A
- VLGEA $2,281,980,000.00
- Revenue This Year
- REPL $31.16
- VLGEA N/A
- Revenue Next Year
- REPL N/A
- VLGEA N/A
- P/E Ratio
- REPL N/A
- VLGEA $9.93
- Revenue Growth
- REPL N/A
- VLGEA 3.96
- 52 Week Low
- REPL $4.92
- VLGEA $24.57
- 52 Week High
- REPL $17.00
- VLGEA $38.70
- Technical
- Relative Strength Index (RSI)
- REPL 39.21
- VLGEA 52.99
- Support Level
- REPL $6.93
- VLGEA $36.24
- Resistance Level
- REPL $10.30
- VLGEA $37.28
- Average True Range (ATR)
- REPL 0.73
- VLGEA 1.04
- MACD
- REPL -0.07
- VLGEA -0.02
- Stochastic Oscillator
- REPL 23.15
- VLGEA 54.44
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.